RESTEGHINI, CARLO
RESTEGHINI, CARLO
Universita' degli Studi di MILANO
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas : Translational analyses and clinical impact
2016 L.D. Locati, F. Perrone, B. Cortelazzi, C. Bergamini, P. Bossi, E. Civelli, C. Morosi, S. Lo Vullo, M. Imbimbo, P. Quattrone, G.P. Dagrada, R. Granata, C. Resteghini, A. Mirabile, S. Alfieri, E. Orlandi, L. Mariani, G. Saibene, S. Pilotti, L. Licitra
A pilot study of a smartphone-based monitoring intervention on head and neck cancer patients undergoing concurrent chemo-radiotherapy
2019 E.M. Zini, G. Lanzola, S. Quaglini, P. Bossi, L. Licitra, C. Resteghini
Big Data in Head and Neck Cancer
2018 C. Resteghini, A. Trama, E. Borgonovi, H. Hosni, G. Corrao, E. Orlandi, G. Calareso, L. De Cecco, C. Piazza, L. Licitra, L. Mainardi
Does a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer?
2016 C. Bergamini, L. Locati, P. Bossi, R. Granata, S. Alfieri, C. Resteghini, M. Imbimbo, C. Fallai, E. Orlandi, S. Tana, N.A. Iacovelli, M. Guzzo, T. Ibba, S. Colombo, R. Bianchi, N. Pizzi, W. Fontanella, L. Licitra
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer
2018 S. Cavalieri, F. Perrone, R. Miceli, P.A. Ascierto, L.D. Locati, C. Bergamini, R. Granata, S. Alfieri, C. Resteghini, D. Galbiati, A. Busico, N. Paielli, R. Patuzzo, A. Maurichi, G. Gallino, R. Ruggeri, L. Mariani, M. Palla, L. Licitra, P. Bossi
Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer
2014 P. Bossi, L. Locati, C. Bergamini, A. Mirabile, R. Granata, M. Imbimbo, C. Resteghini, L. Licitra
Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapy
2016 A. Mirabile, C. Vismara, F. Crippa, P. Bossi, L. Locati, C. Bergamini, R. Granata, C. Resteghini, E. Conte, D. Morelli, P. Scarpellini, L. Licitra
HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patients
2023 S. Cavalieri, I. Nuzzolese, A. Ottini, C. Bergamini, C. Resteghini, E. Colombo, S. Alfieri, P. Quattrone, G. Calareso, N.A. Iacovelli, M. Franceschini, L. Licitra
Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
2021 S. Cavalieri, D.M. Filippini, A. Ottini, C. Bergamini, C. Resteghini, E. Colombo, R. Lombardo, I. Nuzzolese, S. Alfieri, L. Licitra, L.D. Locati
Locally advanced epithelial sinonasal tumors: The impact of multimodal approach
2019 E. Orlandi, S. Cavalieri, R. Granata, P. Nicolai, P. Castelnuovo, C. Piazza, A. Schreiber, M. Turri-Zanoni, P. Quattrone, R. Miceli, G. Infante, F. Sessa, C. Facco, G. Calareso, N.A. Iacovelli, D. Mattavelli, A. Paderno, C. Resteghini, L.D. Locati, L. Licitra, P. Bossi
Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients
2017 C. Resteghini, S. Cavalieri, D. Galbiati, R. Granata, S. Alfieri, C. Bergamini, P. Bossi, L.F.L. Licitra, L..D. Locati
Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic
2021 S. Cavalieri, E. Colombo, A. Bottiglieri, G. Massa, F. Platini, A. Ottini, D. Filippini, E. Zattarin, C. Bergamini, C. Resteghini, S. Alfieri, V. Di Martino, V. Tiraferri, L. Locati, L. Licitra
PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with Anti-Epidermal Growth Factor Receptor Agents
2019 S. Cavalieri, F. Perrone, M. Milione, A. Bianco, S. Alfieri, L.D. Locati, C. Bergamini, C. Resteghini, D. Galbiati, F. Platini, L. Licitra, P. Bossi
Phase II trial with axitinib in recurrent and/or metastatic salivary gland cancers of the upper aerodigestive tract
2019 L.D. Locati, S. Cavalieri, C. Bergamini, C. Resteghini, S. Alfieri, G. Calareso, P. Bossi, F. Perrone, E. Tamborini, P. Quattrone, R. Granata, D. Galbiati, F. Platini, E. Orlandi, L. Mariani, L. Licitra
Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma
2016 P. Bossi, C. Resteghini, N. Paielli, L. Licitra, S. Pilotti, F. Perrone
Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands
2020 S. Cavalieri, L. Mariani, V. Vander Poorten, L. Van Breda, M.C. Cau, S. Lo Vullo, S. Alfieri, C. Resteghini, C. Bergamini, E. Orlandi, G. Calareso, P. Clement, E. Hauben, F. Platini, P. Bossi, L. Licitra, L.D. Locati
Prognostic role of primary tumor, nodal neck, and retropharyngeal GTVs for unresectable sinonasal cancers treated with IMRT and chemotherapy
2019 L. Ferella, A. Cavallo, R. Miceli, N.A. Iacovelli, T. Giandini, E. Pignoli, G. Calareso, P. Bossi, C. Resteghini, G.L. Gravina, P. Nicolai, P. Castelnuovo, C. Piazza, L. Licitra, C. Fallai, E. Orlandi
Prolonged response using gefitinib followed by sirolimus for advanced cutaneous squamous cell carcinoma
2012 P. Bossi, C. Resteghini, F. Perrone, B. Cortelazzi, S. Pilotti, A. Maurichi, L.D. Locati, L. Licitra
RANK expression in EBV positive nasopharyngeal carcinoma metastasis: A ready-to-treat target?
2017 C. Resteghini, S. Alfieri, P. Quattrone, F. Dominoni, G. Garzone, E. Orlandi, L. Locati, C. Bergamini, D. Galbiati, N.A. Iacovelli, C. Fallai, L. Licitra, P. Bossi
Relevance of apparent diffusion coefficient features for a radiomics-based prediction of response to induction chemotherapy in sinonasal cancer
2020 M. Bologna, G. Calareso, C. Resteghini, S. Sdao, E. Montin, V. Corino, L. Mainardi, L. Licitra, P. Bossi